Asymmetrical dimethylarginine and risk of acute coronary events

被引：4

作者：

Brzosko, S ^{[1
]}

Krauze-Brzosko, K

de Gaetano, G

Iacoviello, L

机构：

[1] Consorzio Mario Negri Sud, Angela Valenti Lab Genet & Environm Risk Factors, I-66030 Santa Maria Imbaro, Italy

[2] Med Acad Bialystok, Dept Nephrol & Internal Med, Bialystok, Poland

[3] Catholic Univ, Ctr High Technol Res & Educ Biomed Sci, Campobasso, Italy

来源：

LANCET | 2002年 / 359卷 / 9317期

关键词：

D O I：

10.1016/S0140-6736(02)08498-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1620 / 1620

页数：1

共 5 条

[1]

Böger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173

[2] Homocysteine impairs the nitric oxide synthase pathway -: Role of asymmetric dimethylarginine [J].

Stühlinger, MC ;

Tsao, PS ;

Her, JH ;

Kimoto, M ;

Balint, RF ;

Cooke, JP .

CIRCULATION, 2001, 104 (21) :2569-2575

[3] Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine [J].

Valkonen, VP ;

Päivä, H ;

Salonen, JT ;

Lakka, TA ;

Lehtimäki, T ;

Laakso, J ;

Laaksonen, R .

LANCET, 2001, 358 (9299) :2127-2128

[4] Importance of asymmetrical dimethylarginine in cardiovascular risk [J].

Vallance, P .

LANCET, 2001, 358 (9299) :2096-2097

[5]

Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674

← 1 →